HF
NAMSW icon

HRT Financial’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

HRT Financial’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,655
Closed -$191K – 3093
2024
Q4 		$191K Sell
13,655
-13,465
-50% -$146K ﹤0.01% 1951
2024
Q3 		$189K Sell
27,120
-3,201
-11% -$24.8K ﹤0.01% 1987
2024
Q2 		$286K Hold
30,321
– – ﹤0.01% 1521
2024
Q1 		$334K Hold
30,321
– – ﹤0.01% 1492
2023
Q4 		$94K Hold
30,321
– – ﹤0.01% 1897
2023
Q3 		$57K Hold
30,321
– – ﹤0.01% 1994
2023
Q2 		$63K Hold
30,321
– – ﹤0.01% 2010
2023
Q1 		$56K Hold
30,321
– – ﹤0.01% 2121
2022
Q4 		$24K Buy
+30,321
New +$25K ﹤0.01% 2164

Other funds holding NAMSW

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

HRT Financial's NAMSW Position: Q1 2025 in Review

HRT Financial sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q1 2025, closing a stake of 13,655 shares — an estimated $191K sold.

HRT Financial first reported a position in NAMSW in Q4 2022 and held it in 9 quarters. The position peaked at $334K in Q1 2024. 10 funds tracked by Wall St. Rank hold NAMSW as of Q1 2025.

  • HRT Financial reported no remaining NewAmsterdam Pharma Warrant position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 13,655 NewAmsterdam Pharma Warrant shares in Q1 2025, an estimated $191K.
  • HRT Financial first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and held it in 9 quarters.
  • HRT Financial's NewAmsterdam Pharma Warrant position peaked at $334K in Q1 2024.
  • 10 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.